MD Anderson Madrid-Hospiten incorporates the innovative CAR-T therapy for the treatment of complex hematological cancers Published on 08/01/2025 This cutting-edge technique modifies immune system cells to specifically identify and destroy cancer cells.
An understanding of the cellular alterations that occur with acute leukemia opens the door to innovative and targeted therapies Published on 03/10/2024 The specialists will give an update on advances in the treatment of myelodysplastic syndromes, myelofibrosis, specific therapies for Acute Myeloid Leukaemia (AML) or Acute Lymphoblastic Leukaemia (ALL).
Numerous developments are enabling ever more personalised leukemia treatments with lower toxicity Published on 19/06/2023 Recent studies have sought to demonstrate the effectiveness of new targeted therapies, such as FLT3 or menin inhibitors, and cellular therapy such as CAR-T in ever earlier scenarios
Bone marrow transplantation is still the only potential option of a cure for hematological tumors Published on 23/02/2023 Bone marrow donation, which may improve the patient's prognosis, does not pose any health risk for the donor nor does it require admission to the operating room
Research into acute leukemia moves towards "tailor-made" treatments for each individual patient Published on 22/11/2022 Research into acute leukemia is currently one of the most active fields in Spain due to the shortcomings persisting in the treatment of these patients, who amount to more than 6,000 every year1
Improves the identification of genetic alterations in leukemia, allowing treatment to be personalized, improving its effectiveness Published on 20/06/2022 Depending on the type of leukemia, patients will have different genetic alterations or mutations that determine the progress of treatment
Hematologists face the challenge of incorporating Target Therapies into daily practice in the treatment of acute leukemia Published on 10/11/2021 Better understanding of cell tumor biology opens possibilities for targeted therapies in acute leukemia
Systemic mastocytosis, a disease of rare diagnosis, to be studied at the 10th Acute Leukemia Conference of MD Anderson Madrid – Hospiten Published on 27/09/2021 It will feature prominent speakers from different countries in America and Europe, as well as the intervention of professionals from the MD Anderson leukemia department in Houston
A decade of hope begins for the treatment of acute myeloid leukemia thanks to new treatments like FLT3 inhibitors Published on 21/06/2021 New drugs, like FLT3 inhibitors, improve survival rates in people with acute myeloid leukemia, acting on altered intracellular signaling pathways that allow cancer cells to grow
MD Anderson Madrid – Hospiten participates in a protocol for bone marrow transplant patients to receive treatment at its center after the procedure Published on 25/02/2021 This allows patients with lymphoma or multiple myeloma who require a hematopoietic stem cell transplant to return to their center of origin to continue their own post-transplant care